*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C92Z2 - Other myeloid leukemia, in relapse - as a primary diagnosis code | C92Z2 - Other myeloid leukemia, in relapse - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 11.67 | |
| Readmission Rate (%) | 47.29 | |
| Unplanned Readmission Rate (%) | 22.82 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 842: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 29,081 | ||||
| Total Hospitalizations with ICD C92Z2 - Other myeloid leukemia, in relapse | 154 | ||||
| DRG Share of Total Hospitalizations | 0.09 | ||||
| % of Total ICD C92Z2 - Other myeloid leukemia, in relapse in DRG | 54.04 | ||||
| Avg LOS at DRG | 9.8 | ||||
| Avg LOS with ICD C92Z2 - Other myeloid leukemia, in relapse | 12.45 | ||||
| Readmission Rate at DRG | 37.3 | ||||
| Readmission Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 37.3 | ||||
| Unplanned Readmission Rate at DRG | 22.57 | ||||
| Unplanned Readmission Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 21.43 | ||||
| Total Medicare payments at DRG | $683,745,757 | ||||
| Total Medicare payments with ICD C92Z2 - Other myeloid leukemia, in relapse | $4,335,876 | ||||
| Total Medicare payment per Day at DRG | $2,399 | ||||
| Total Medicare payment per Day with ICD C92Z2 - Other myeloid leukemia, in relapse | $2,262 | ||||
| Total Medicare payment per Hospitalization at DRG | $23,512 | ||||
| Total Medicare payment per Hospitalization with ICD C92Z2 - Other myeloid leukemia, in relapse | $28,155 | ||||
| Total Medicare Charges at DRG | $3,049,100,784 | ||||
| Total Medicare Charges with ICD C92Z2 - Other myeloid leukemia, in relapse | $21,370,340 | ||||
| Avg Charges at DRG | $104,849 | ||||
| Avg Charges with ICD C92Z2 - Other myeloid leukemia, in relapse | $138,768 | ||||
| Mortality Rate at DRG | 13.07 | ||||
| Mortality Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 14.94 | ||||
| SNF Discharge Rate at DRG | 16.93 | ||||
| SNF Discharge Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 29.4 | ||||
| Home Discharge Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 47.4 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 63 |
| ARTHUR G JAMES CANCER HOSPITAL | 300 W 10TH AVE | COLUMBUS | OH | 43210 | 11 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 29,081 | ||||
| Total Hospitalizations with ICD C92Z2 - Other myeloid leukemia, in relapse | 155 | ||||
| DRG Share of Total Hospitalizations | 0.09 | ||||
| % of Total ICD C92Z2 - Other myeloid leukemia, in relapse in DRG | 15.72 | ||||
| Avg LOS at DRG | 9.8 | ||||
| Avg LOS with ICD C92Z2 - Other myeloid leukemia, in relapse | 12.39 | ||||
| Readmission Rate at DRG | 37.3 | ||||
| Readmission Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 37.01 | ||||
| Unplanned Readmission Rate at DRG | 22.57 | ||||
| Unplanned Readmission Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 21.26 | ||||
| Total Medicare payments at DRG | $683,745,757 | ||||
| Total Medicare payments with ICD C92Z2 - Other myeloid leukemia, in relapse | $4,363,844 | ||||
| Total Medicare payment per Day at DRG | $2,399 | ||||
| Total Medicare payment per Day with ICD C92Z2 - Other myeloid leukemia, in relapse | $2,273 | ||||
| Total Medicare payment per Hospitalization at DRG | $23,512 | ||||
| Total Medicare payment per Hospitalization with ICD C92Z2 - Other myeloid leukemia, in relapse | $28,154 | ||||
| Total Medicare Charges at DRG | $3,049,100,784 | ||||
| Total Medicare Charges with ICD C92Z2 - Other myeloid leukemia, in relapse | $21,428,548 | ||||
| Avg Charges at DRG | $104,849 | ||||
| Avg Charges with ICD C92Z2 - Other myeloid leukemia, in relapse | $138,249 | ||||
| Mortality Rate at DRG | 13.07 | ||||
| Mortality Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 14.84 | ||||
| SNF Discharge Rate at DRG | 16.93 | ||||
| SNF Discharge Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 29.4 | ||||
| Home Discharge Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 47.74 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 45,065 | ||||
| Total Hospitalizations with ICD C92Z2 - Other myeloid leukemia, in relapse | 60 | ||||
| DRG Share of Total Hospitalizations | 0.14 | ||||
| % of Total ICD C92Z2 - Other myeloid leukemia, in relapse in DRG | 6.09 | ||||
| Avg LOS at DRG | 4.03 | ||||
| Avg LOS with ICD C92Z2 - Other myeloid leukemia, in relapse | 8.37 | ||||
| Readmission Rate at DRG | 66.75 | ||||
| Readmission Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 55.0 | ||||
| Unplanned Readmission Rate at DRG | 10.94 | ||||
| Unplanned Readmission Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 28.33 | ||||
| Total Medicare payments at DRG | $438,494,977 | ||||
| Total Medicare payments with ICD C92Z2 - Other myeloid leukemia, in relapse | $1,149,012 | ||||
| Total Medicare payment per Day at DRG | $2,416 | ||||
| Total Medicare payment per Day with ICD C92Z2 - Other myeloid leukemia, in relapse | $2,289 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,730 | ||||
| Total Medicare payment per Hospitalization with ICD C92Z2 - Other myeloid leukemia, in relapse | $19,150 | ||||
| Total Medicare Charges at DRG | $2,145,591,374 | ||||
| Total Medicare Charges with ICD C92Z2 - Other myeloid leukemia, in relapse | $6,106,665 | ||||
| Avg Charges at DRG | $47,611 | ||||
| Avg Charges with ICD C92Z2 - Other myeloid leukemia, in relapse | $101,778 | ||||
| Mortality Rate at DRG | 0.08 | ||||
| Mortality Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA | ||||
| SNF Discharge Rate at DRG | 4.35 | ||||
| SNF Discharge Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 81.76 | ||||
| Home Discharge Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | 80.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 842: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 6,280 | ||||
| Total Hospitalizations with ICD C92Z2 - Other myeloid leukemia, in relapse | 15 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C92Z2 - Other myeloid leukemia, in relapse in DRG | 1.52 | ||||
| Avg LOS at DRG | 3.66 | ||||
| Avg LOS with ICD C92Z2 - Other myeloid leukemia, in relapse | 3.53 | ||||
| Readmission Rate at DRG | 36.18 | ||||
| Readmission Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA | ||||
| Unplanned Readmission Rate at DRG | 17.17 | ||||
| Unplanned Readmission Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA | ||||
| Total Medicare payments at DRG | $48,340,480 | ||||
| Total Medicare payments with ICD C92Z2 - Other myeloid leukemia, in relapse | $161,651 | ||||
| Total Medicare payment per Day at DRG | $2,103 | ||||
| Total Medicare payment per Day with ICD C92Z2 - Other myeloid leukemia, in relapse | $3,050 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,698 | ||||
| Total Medicare payment per Hospitalization with ICD C92Z2 - Other myeloid leukemia, in relapse | $10,777 | ||||
| Total Medicare Charges at DRG | $249,811,104 | ||||
| Total Medicare Charges with ICD C92Z2 - Other myeloid leukemia, in relapse | $418,054 | ||||
| Avg Charges at DRG | $39,779 | ||||
| Avg Charges with ICD C92Z2 - Other myeloid leukemia, in relapse | $27,870 | ||||
| Mortality Rate at DRG | 1.59 | ||||
| Mortality Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA | ||||
| SNF Discharge Rate at DRG | 7.25 | ||||
| SNF Discharge Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 68.04 | ||||
| Home Discharge Rate with ICD C92Z2 - Other myeloid leukemia, in relapse | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 127 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 43 |
| ARTHUR G JAMES CANCER HOSPITAL | 300 W 10TH AVE | COLUMBUS | OH | 43210 | 36 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 11 |